Clinical Research Directory
Browse clinical research sites, groups, and studies.
Effects of Reducose on Postprandial Glycemic Levels in Obese Children and Adolescents
Sponsor: University of Bari Aldo Moro
Summary
The study entitled "Effects of Reducose on Postprandial Glycemic Peak in Obese Children and Adolescents: A Pilot Study" aims to evaluate the improvement in glycemic and insulinemic levels produced by Reducose, a food supplement extracted from white mulberry (Morus alba), after 12 weeks of treatment in a cohort of obese children and adolescents. Clinical and anthropometric data (age, sex, weight, height, BMI, pubertal stage) will be collected, along with data from blood chemistry tests performed during routine follow-up visits, in accordance with Good Clinical Practice guidelines.
Official title: Effects of Reducose on Postprandial Glycemic Levels in Obese Children and Adolescents: A Pilot Study (PEDRED)
Key Details
Gender
All
Age Range
6 Years - 16 Years
Study Type
INTERVENTIONAL
Enrollment
80
Start Date
2025-06-01
Completion Date
2026-06-30
Last Updated
2026-03-27
Healthy Volunteers
No
Conditions
Interventions
Reducose
Reducose 250 mg oral sticks, administered twice daily, 1 at lunch and 1 at dinner, for 12 weeks
Placebo
Participants will receive 2 placebo sticks per day, 1 at lunch and 1 at dinner, for 12 weeks. The placebo sticks will be indistinguishable from the active product and will contain inert excipients.
Locations (1)
Ospedale Pediatrico Giovanni XXIII
Bari, Italy